参考文献/References:
[1] Stamler J,Vaccaro 0,Neaton JD,et al.Diabetes,other risk factors,and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Tria1[J].Diabetes Care,1993,l6(2):434-444.
[2] 刘力生.中国高血压防治指南2010[J].中国医学前沿杂志(电子版),2011,3(5):42-93.
[3] Cooper-Dehoff RM,Pacanowski MA,Pepine CJ.Cardiovascular therapies and associated glucose homeostasis:implications across the dysglycemia continuum[J]. J Am Coll Cardiol, 2009,53(5 suppl):S28-S34.
[4] Balogun WO,Salako BL. Co-occurrence of diabetes and hypertension: Pattern and factors associated with order of diagnosis among Nigerians[J].Ann Ib Postgrad Med, 2011,9(2):89-93.
[5] Lastra G,Syed S,Kurukulasuriya LR,et al.Type 2 diabetes mellitus and hypertension:an update[J]. Endocrinol Metab Clin North Am, 2014, 43(1):103-122.
[6] 孙中明,潘恩春,缪丹丹,等.淮安市2型糖尿病合并高血压患者血压控制情况及其影响因素分析[J].中国慢性病预防与控制, 2017, 25(11):806-809.
[7] Adler AI. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study[J]. BMJ, 2000, 321(7258):412-419.
[8] ADVANCE Collaborative Group,Patel A,MacMahon S,et al.Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes[J]. N Engl J Med,2008,358(24):2560-2572.
[9] Ji L,Hu D,Pan C,et al. Primacy of the 3B approach to control risk factors for cardiovascular disease in type 2 diabetes patients[J].Am J Med, 2013, 126(10):925.e11-e22.
[10] 孙宁玲,王鸿懿.我国高血压专病门诊患者血压控制及糖代谢调查现状分析[J]. 中华高血压杂志,2013,52(8):654-658.
[11] 林凡礼,战义强,贾贡献,等.中国门诊高血压患者血压达标现状及影响因素分析[J].中华高血压杂志, 2013(2):170-174.
[12] Suresh Kumar P, Sandhya AM. A study on the glycemic, lipid and blood pressure control of type 2 diabetes patients of Kerala[J]. Diabetes Metab Syndr, 2017,11(4):231-235.
[13] Grenier J,Goodman SG, Leiter LA, et al. Blood pressure?management?in adults with type 2?diabetes:?insights?from the?diabetes mellitus Status?in?Canada?(DM-SCAN)?survey[J]. Can JDiabetes,2018,42(2):130-137.
[14] Rehman H, Akeroyd JM, Ramsey D, et al. Facility-level variation in diabetes and blood pressure control in patients with diabetes: Findings from the Veterans Affairs national database[J]. Clin Cardiol, 2017,40(11):1055-1060.
[15] 秦明照,袁申元,傅汉菁,等.北京市15个社区2型糖尿病患者合并高血压率及血压达标的调查[J]. 中华全科医师杂志, 2013, 12(7):537-540.
[16] 杨群娣,阮晔,黎衍云,等.上海市社区管理2型糖尿病患者的血糖、血压及血脂控制情况分析[J].中国慢性病预防与控制,2015,23(8):561-564.
[17] Meneilly GS,Berard LD,Cheng AYY, et al. Insights into the current management of older adults with type 2 diabetes in the ontario primary care setting[J]. Can J Diabetes, 2018,42(1):23-30.
[18]Whelton PK,Carey RM,Aronow WS,et al.2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults[J]. J Am Coll Cardiol,2017,71(19):213-221.
[19] James PA,Oparil S,Carter BL,et al.2014 evidence-based guideline for the management of high blood pressure in adults:report from the panel members appointed to the eighth Joint National Committee (JNC 8)[J].JAMA,2014,311(5): 507-520.
[20] 贾伟平,纪立农,翁建平,等.中国2型糖尿病防治指南(2017年版)[J].中国实用内科杂志,2018, 38(4):34-86.
[21] 王文.CSC 2016:中国高血压防治指南修订问题的解读[J].实用心脑肺血管病杂志, 2016,24(9):24-24.
[22] 罗富健,黄建凤.低舒张压与心血管疾病关系的研究进展[J].心血管病学进展, 2016,37(5):486-490.
[23] Xie X,Atkins E,Lv J. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis[J]. Lancet,?2016,387(10017):435-443.
[24] Lv J, Ehteshami P, Sarnak MJ, et al. Effects of intensive blood pressure lowering on the progression of chronic kidney disease:a systematic review and meta-analysis[J]. CMAJ,2013,185(11):949-957.
[25] Emdin CA,Rahimi K,Neal B, et al. Blood pressure lowering in type 2 diabetes:a systematic review and meta-analysis[J].JAMA,2015,313(6):603-615.
[26] Brunstr?m M,Carlberg B. Effect of antihypertensive treatment at different blood pressure levels in patients with diab etes mellitus: systematic review and meta-analyses[J]. BMJ, 2016, 352: i717.
[27] Bangalore S,Toklu B,Gianos E,et al.Optimal systolic blood pressure target after SPRINT insights from a network meta-analysis of randomized trials[J].Am J Med, 2017,130(6):707-719.
[28] Bundy JD,Li C, Stuchlik P,et al. Systolic blood pressure reduction and risk of cardiovascular disease and mortality:a systematic review and network meta-analysis[J]. JAMA Cardiol, 2017,2(7):775-781.
[29] Wright JT,Williamson JD,Whelton PK,et al. A randomized trial of intensive versus standard blood-pressure control[J]. N Engl J Med, 2016, 42(8):e141-e143.
[30] ACCORD Study Group. Effects of intensive blood pressure control in type 2 diabetes[J]. N Engl J Med,2010,362(17):1575-1585.
[31] Margolis KL,O’Connor PJ,Morgan TM,et al.Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes:the ACCORD randomized trial[J]. Diabetes Care, 2014, 37(6):1721-1728.
[32] Soliman EZ,Byington RP,Bigger JT,et al. Effect of intensive blood pressure lowering on left ventricular hypertrophy in patients with diabetes mellitus[J]. Hypertension,2015,66(6):1123-1129.
[33] Buckley LF, Dixon DL, Wohlford GF, et al. Effect of intensive blood pressure control in patients with type 2 diabetes mellitus over 9 years of follow-up: A subgroup analysis of high-risk ACCORDION trial participants[J].Diabetes Obes Metab,2018, 20(6):1499-1502.
相似文献/References:
[1]孙刚,黄冠华,综述.高血压合并心力衰竭的治疗策略[J].心血管病学进展,2016,(2):201.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.027]
SUN Gang,HUANG Guanhua.Treatment Strategy of Hypertension with Heart Failure[J].Advances in Cardiovascular Diseases,2016,(7):201.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.027]
[2]张若愚,综述,殷跃辉,等.2型糖尿病及其药物对心房颤动的影响[J].心血管病学进展,2016,(4):337.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.003]
ZHANG Ruoyu,YIN Yuehui.Effect of Type 2 Diabetes Mellitus and Diabetic Drugs on Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(7):337.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.003]
[3]范贵娟,综述,徐瑞,等.盐敏感性高血压的研究进展[J].心血管病学进展,2016,(4):364.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.010]
FAN Guijuan,XU Rui.Research Progress of Salt Sensitive Hypertension[J].Advances in Cardiovascular Diseases,2016,(7):364.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.010]
[4]陈源源.钙通道阻滞剂在降压治疗中的应用[J].心血管病学进展,2015,(6):662.[doi:10.3969/j.issn.1004-3934.2015.06.002]
CHEN Yuanyuan.Application of Calcium Channel Blockers in Hypertension Treatment[J].Advances in Cardiovascular Diseases,2015,(7):662.[doi:10.3969/j.issn.1004-3934.2015.06.002]
[5]张瑞 毛露 孙硕 Dirk Hermann 陈艾东.内皮素-1干预成为高血压治疗新靶点的展望[J].心血管病学进展,2019,(7):969.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.000]
ZHANG Rui MAO LuSUN ShuoDIRK Hermann CHEN Aidong.The Prospect of Endothelin-1 Intervention as A New Target for the Treatment of Hypertension[J].Advances in Cardiovascular Diseases,2019,(7):969.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.000]
[6]张毅,柳志红.动态血压监测在高血压中的应用现状与问题[J].心血管病学进展,2019,(6):848.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.003]
ZHANG Yi,LIU Zhihong.Current status and nsolved Pproblems of Ambulatory Blood Pressure Monitoring for the Management of Hypertension[J].Advances in Cardiovascular Diseases,2019,(7):848.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.003]
[7]张旭明 王曦.高血压对认知功能的影响[J].心血管病学进展,2019,(7):977.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.003]
ZHANG Xuming,WANG Xi.The Relationship Between Hypertension and Cognitive Function[J].Advances in Cardiovascular Diseases,2019,(7):977.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.003]
[8]凌梦军 陈明凌梦军.阻塞性睡眠呼吸暂停低通气综合征与高血压关系的研究进展[J].心血管病学进展,2019,(5):722.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.015]
[9]李波 郭毅 田进文 邓珏琳.高血压合并2型糖尿病的治疗进展[J].心血管病学进展,2019,(9):1196.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.002]
LI Bo,GUO Yi,TIAN Jinwen,et al.Therapy in Hypertensive Patients with Type 2 Diabetes Mellitus[J].Advances in Cardiovascular Diseases,2019,(7):1196.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.002]
[10]王继航 赵施皓 李开亮 田进文 李玉龙 付士辉 沈明志 邓珏琳.远程医疗在高血压病管理中的研究进展[J].心血管病学进展,2019,(9):1199.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.003]
WANG Jihang,ZHAO Shihao,LI Kailiang,et al.Telemedicine in Hypertension Management[J].Advances in Cardiovascular Diseases,2019,(7):1199.[doi:10.16806/j.cnki.issn.1004-3934.2019.09.003]
[11]邹昕宇 杨帆 吴建军 邢磊.端粒长度在心脑血管疾病的研究进展[J].心血管病学进展,2022,(12):1131.[doi:10.16806/j.cnki.issn.1004-3934.2022.12.017]
ZOU Xinyu,YANG Fan,WU Jianjun,et al.Telomere Length in Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2022,(7):1131.[doi:10.16806/j.cnki.issn.1004-3934.2022.12.017]
[12]张啸,刘剑刚,董国菊.射血分数保留性心力衰竭常见合并症的病理机制及治疗策略[J].心血管病学进展,2024,(2):125.[doi:10.16806/j.cnki.issn.1004-3934.2023.02.007]
ZHANG Xiao,LIU Jiangang.The Pathophysiology and Treatment Strategies of Comorbidities in HFpEF[J].Advances in Cardiovascular Diseases,2024,(7):125.[doi:10.16806/j.cnki.issn.1004-3934.2023.02.007]